Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 known ✓ | P08172 | 2/20 | 0.39 |
| ▸ | CHRM1 known ✓ | P11229 | 1/20 | 0.39 |
| ▸ | CHRM3 known ✓ | P20309 | 1/20 | 0.39 |
| ▸ | SLC6A2 known ✓ | P23975 | 1/20 | 0.39 |
| ▸ | ACHE known ✓ | P22303 | 2/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | SCN1A | P35498 | 2/20 | 0.40 |
| ▸ | SCN2A | Q99250 | 2/20 | 0.40 |
| ▸ | SCN3A | Q9NY46 | 2/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.39 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.39 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.39 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.39 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.39 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.39 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.38 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.38 |
| ▸ | BCHE | P06276 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28640892 | 0.78 | LMNA (0.46) | TAAR1KMT2ACHRM2CYP2D6CHRM1 | |
| Hydrochloric Acid SCHEMBL9459954 | 0.78 | HTR2A (0.46) | KMT2ACHRM2CYP2D6CHRM1ADRA2C | |
| Hydrochloric Acid SCHEMBL4193707 | 0.77 | SMN1; SMN2 (0.47) | KMT2ACHRM2CHRM1ADRA2CCHRM3 | |
| Hydrochloric Acid SCHEMBL4188748 | 0.77 | MEN1 (0.47) | KMT2AACHEBCHETSHRMEN1 | |
| Hydrochloric Acid SCHEMBL6441812 | 0.77 | CHRM2 (0.50) | TAAR1KMT2ACHRM2CHRM1CYP11B1 | |
| Hydrochloric Acid SCHEMBL8615986 | 0.77 | CYP2D6 (0.61) | TAAR1KMT2ACHRM2CYP2D6CHRM1 | |
| SCHEMBL9858134 | 0.75 | CHRM2 (0.52) | TAAR1KMT2ACHRM2CHRM1CYP11B1 | |
| SCHEMBL20590195 | 0.74 | CHRM2 (0.39) | CHRM2CYP2D6CHRM1ADRA2CCHRM3 | |
| SCHEMBL212194 | 0.74 | CYP2D6 (0.63) | TAAR1KMT2ACHRM2CYP2D6CHRM1 | |
| SCHEMBL20590194 | 0.74 | CHRM2 (0.39) | CHRM2CYP2D6CHRM1ADRA2CCHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118239957-A | Process for the preparation of 2-exo- (2-methylbenzyloxy) -1-methyl-4-isopropyl-7-oxabicyclo [2.2.1] heptane | 巴斯夫农业公司 | 2024-06-25 | — | — | CN | disclosed |
| CN-110337438-B | Process for the preparation of 2-exo- (2-methylbenzyloxy) -1-methyl-4-isopropyl-7-oxabicyclo [2.2.1] heptane | 巴斯夫农业公司 | 2024-03-26 | — | — | CN | disclosed |
| US-10710969-B2 | Process for preparing 2-exo-(2-methylbenzyloxy)-1-methyl-4-isopropyl-7-oxabicyclo[2.2.1]heptane | BASF Agro B.V. (NL) | 2020-07-14 | — | — | US | disclosed |
| EP-3601295-A1 | PROCESS FOR PREPARING 2-EXO-(2-METHYLBENZYLOXY)-1-METHYL-4-ISOPROPYL-7-OXABICYCLO[2.2.1]HEPTANE | BASF Agro B.V. (NL) | 2020-02-05 | — | — | EP | disclosed |
| US-20200031792-A1 | Process for Preparing 2-exo-(2-Methylbenzyloxy)-1-methyl-4-isopropyl-7-oxabicyclo[2.2.1]heptane | BASF SE (DE) | 2020-01-30 | — | — | US | disclosed |
| WO-2018177907-A1 | PROCESS FOR PREPARING 2-EXO-(2-METHYLBENZYLOXY)-1-METHYL-4-ISOPROPYL-7-OXABICYCLO[2.2.1]HEPTANE | BASF Agro B.V. (NL) | 2018-10-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200031792-A1 | Process for Preparing 2-exo-(2-Methylbenzyloxy)-1-methyl-4-isopropyl-7-oxabicyclo[2.2.1]heptane | EXOC1, ADH1C, EXOC4 | CHRM2 289/4885CHRM1 69/4885CHRM3 867/4885 |
| US-10710969-B2 | Process for preparing 2-exo-(2-methylbenzyloxy)-1-methyl-4-isopropyl-7-oxabicyclo[2.2.1]heptane | EXOC1, ADH1C, EXOC4 | CHRM2 289/4885CHRM1 69/4885CHRM3 867/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.